Acne Treatment Market Trends —
The global acne treatment market size is likely to grow at a healthy 5.3% CAGR between 2017- 2023, according to the new report by Market Research Future (MRFR). Acne, also called acne vulgaris, simply put, is a skin condition that is characterized by clogging of hair follicles with dead skin cells or oil. This can persist after the treatment as well. Acne is likely to affect the part of the skin that has more oil glands, that is, the back, the face, and the upper portion of the chest. Some of its common symptoms include papules, cystic lesions, nodules, and pustules.
Various factors are adding to the acne treatment industry growth. According to the new MRFR report, such factors include increasing consciousness about physical appearance, increasing inclination towards home remedies for its fastest effect & cost-effectiveness, increasing prevalence of acne due to unhealthy lifestyle and increasing pollution level, and rising prevalence of acne in teenage population for hormonal activity.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5675
On the contrary, adverse side effects such as sensitivity according to the skin type may limit the acne treatment market growth over the forecast period.
Acne Treatment Market Segmentation
The MRFR report gives an inclusive segmental analysis of the global acne treatment market report based on treatment modality, end users, treatment, & type.
By type, the global acne treatment market is segmented into inflammatory acne, post-surgical/wound acne, comedonal acne, cystic acne, and others.
By treatment, the global acne treatment market is segmented into therapeutic devices, medication, & others. Medication is further segmented into antibiotics, retinoid, & others. Retinoid is further segmented into adapalene, tretinoin, & others. Antibiotics are further segmented into clindamycin, erythromycin, and others. Therapeutic devices are again segmented into microdermabrader, lasers, dermabradors, and others.
By treatment modality, the global acne treatment market is segmented into topical, injectable, and oral.
By end users, the global acne treatment is segmented into ambulatory surgical centers, pharmacies and drug stores, and others.
Acne Treatment Market Regional Analysis
Based on the region, the global acne treatment market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. The presence of various developed economies in the region namely Canada & the US, increasing cosmetic expenditure, changing lifestyle, huge patient population, and the presence of a well-developed healthcare sector is adding to the acne treatment market growth in the region.
The global acne treatment market in Europe is predicted to hold the second-largest share over the forecast period. Increasing teenage population, massive patient population, & availability of funds for research are adding to the acne treatment market growth in the region.
The global acne treatment market in the APAC region is predicted to grow at a fast pace over the forecast period. Developing economies especially China as well as India, developing healthcare sector, and the rising prevalence of acne are adding to the acne treatment market growth over the forecast period.
The global acne treatment market in the MEA is predicted to have the smallest share over the forecast period. Lack of healthcare services, stringent government policies, and the presence of poor economies is resulting in a small market share. In the Middle East, however, the market will have a good share for huge healthcare expenditure by Dubai, Kuwait, & Saudi Arabia and the presence of a well-developed healthcare sector.
Acne Treatment Market Key Players
Eminent players profiled in the acne treatment market report comprise Teva Pharmaceutical Industries Ltd. (Israel), Johnson & Johnson Services, Inc. (U.S.), Roche Holding AG (Switzerland), Bayer AG (Germany), GlaxoSmithKline Plc. (U.K), Valeant (Canada), Galderma S.A. (Switzerland), Stiefel Laboratories, Inc. (U.S.), and ALLERGAN (Republic of Ireland).
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/acne-treatment-market-5675
Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Browse More Healthcare Reports at:
Immunotherapy Drugs Market: Global Immunotherapy Drugs Market size is expected to exhibit a strong 8.9% CAGR over the forecast period
Digital Health Market: Digital Health Market size is touted to reach USD 328,887.8 million by 2025. It is expected to score a CAGR of 26.30% during the assessment period
Botulinum Toxin Market: Global Botulinum Toxin Market size is expected to reach USD 9442.93 million with a CAGR of 10.3% by 2025
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Phone: +1 646 845 9312
Release ID: 88965750